Parameter
| Biomarker | Gut microbiota | Full name | Gut microbiota | Molecular Type | Microorganism |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Early diagnosis、Risk assessment |
| Disease | Chronic Kidney Disease (CKD) | Disease Subtypes | / | ||
| Organ | Kidney | Test Sample / Technology Platform | Feces, blood ( metagenomic sequencing, flora analysis ) | ||
| Pathobiological Mechanisms | The progress of CKD leads to the imbalance of intestinal flora, the decrease of probiotics and the increase of pathogenic bacteria, which leads to the damage of intestinal | ||||
| Clinical Availability Status | Research and exploration stage | ||||
| Notes and Dynamics | The metabolites of intestinal flora ( such as indole and phenols ) can be used as uremic toxins to aggravate kidney damage, and related markers are expected to become non-invasive screening tools. | ||||